| 1 |
[GO] |
2025―Jan―17 |
Impact of COVID-19 on gut-lung microbiota a mini review |
Reza Emadi, Parastoo Yousefi, Alireza Tabibzadeh |
| 2 |
[GO] |
2025―Jan―08 |
Are we ready for the next pandemic: Disease X |
Ali Kemal Erenler, Behice Hande Erenler, Ahmet Baydin |
| 3 |
[GO] |
2025―Jan―03 |
Antibody responses after COVID-19 vaccination: a cross sectional study among the Bangladeshi population |
Moumita Das, A.F.M. Tareq Bhuiyan, Md. Hasanul Karim, Md. Amzad Hossain, Md. Abdur Rob, Shamim Khan, Jannatun Wnaiza, Rony Chandra Shil, Mohabbat Hossain, Nahidur Rahman, Farjana Sharmen, Afroza Akter Tanni, S.M. Rafiqul Islam, Adnan Mannan |
| 4 |
[GO] |
2024―Nov―14 |
Knowledge, perception, and attitudes regarding the new COVID-19 delta variant pandemic among medical health workers and patients at the National Center of Hematology |
Huda Ibraheem Abd AL-Lateef, Shahla’a Fadhil Sabir, Mayadah Mohammed Ridha |
| 5 |
[GO] |
2024―Nov―14 |
COVID-19 omicron variant: variation from other variants, immune response, and vaccination against this rapidly spreading pandemic |
Yasmen Mahmoud, Amira Hathout, Radwa Abdallnasser Amen, Sara Desouky, Rawan Muhammad Shady, Heba Mohamed Fahmy |
| 6 |
[GO] |
2024―Nov―14 |
A review of SARS-CoV-2 virology, vaccines, variants and their impact on the COVID-19 pandemic |
Tetsuyuki Hirahata, Reeshan ul Quraish, Afraz ul Quraish, Shahan ul Quraish |
| 7 |
[GO] |
2024―Nov―14 |
Procalcitonin, C-reactive protein, ferritin and interleukin-37 levels among COVID-19 patients in the presence or absence of secondary bacterial infections |
Aliaa Jabbar Qasim, Eman Natiq Naji, Suad Almas Brakhas |
| 8 |
[GO] |
2024―Nov―14 |
Airway management in patients with COVID-19: an updated guide for clinicians in the emergency department |
Ali Kemal Erenler, Seval Komut, Mustafa Çapraz, Ahmet Baydin |
| 9 |
[GO] |
2024―Nov―14 |
Severe acute respiratory syndrome coronavirus 2 and Legionella co-infection in a child with sleep disorder: a case report |
Shirin Dashtbin, Saba Jalalifar, Gholamreza Bayazian, Gholamreza Irajian, Alireza Nateghian |
| 10 |
[GO] |
2024―Nov―14 |
Vitamin D and immune response against severe acute respiratory syndrome coronavirus 2 in older adults: does it really work? |
Adriana B. Pedreáñez, Jesús A. Mosquera-Sulbarán, Nelson E. Muñáz, Diego M. Tene, Jorge G. Robalino |
| 11 |
[GO] |
2024―Nov―14 |
Severe acute respiratory syndrome coronavirus 2 pandemic and older people: what we know about the clinical, laboratory, imaging features, and clinical outcomes |
Shereen Abdel Alem, Ahmed Moustafa |
| 12 |
[GO] |
2024―Nov―14 |
Thromboembolism: the secret lethal weapon of coronavirus disease 2019 |
Abdulrahman K. Ahmed, Eslam R. Moustafa, Aya M. Abd EL-Monem, Galal A. Hasan, Omar A. Mohamed, Islam H. Ibrahim, Gaber El-Saber Batiha, Israa M.S. Al-Kadmy, Amal Hosni, Helal F. Hetta |
| 13 |
[GO] |
2024―Nov―14 |
Single nucleotide polymorphism in toll-like receptor 3 gene as a potential risk factor for severe outcome of coronavirus disease 2019 |
Mehdi Ramshini, Farah Bokharaei-Salim, Tahereh Donyavi, Majid Khoshmirsafa, Saied Ghorbani, Alireza Khatami, Mohammad Abbasi-Kolli, Alireza Safi Deh Naeini, Ensieh Jafari, Ahmad Tavakoli, Seyed Hamidreza Monavari, Anjila Ataei-Pirkooh, Zohreh Yousefi Ghalejoogh, Seyed Jalal Kiani |
| 14 |
[GO] |
2024―Nov―14 |
Applications of nanotechnology in the fight against coronavirus disease 2019 |
Reem Sayad, Huda Ahmed Abdelsabour, Samia Mohamed Farhat, Nehal Gamal Omer, Manar Magdy Ahmed, Ibrahim Khalid Elsayh, Islam H. Ibrahim, Abdelazeem M. Algammal, Israa M.S. AL-Kadmy, Gaber El-Saber Batiha, Helal F. Hetta |
| 15 |
[GO] |
2024―Nov―14 |
Knowledge, attitude and practice towards coronavirus disease 2019 among Indian residents - an online cross-sectional survey |
Kalaivani Manokaran, Saritha Kamath U., Aneena Varghese, Ravi Shankar N., Siddharth Kaushik, Shiek Fareeth Ahmed, Robert Selvam, Prabu Paramasivam, Anju M. |
| 16 |
[GO] |
2024―Nov―14 |
Diagnostic performance of two commercially available coronavirus disease 2019 antibody kits: Elecsys Anti-SARS CoV-2 (Roche) and Anti-SARS-CoV-2 ELISA (IgG) (Euroimmun) |
Abdurrahman Sarmis, Mucahide Esra Kocoglu, Hasan Guclu, Zafer Habip, Tuncer Ozekinci |
| 17 |
[GO] |
2022―May―25 |
Intravenous immunoglobulin and treatment in COVID-19 patients: case series |
Negar Mohtadi, Abas Ghaysouri, Ali Nazari, Jalil Feizi, Hamed Tavan |
| 18 |
[GO] |
2022―Jan―20 |
The effectiveness of the immune responses to SARS-CoV-2 |
Barik A. Salih |
| 19 |
[GO] |
2021―Jun―06 |
Coronavirus disease 2019 |
Yeruva Thirupathaiah, Anuj Kumar Chandel |
| 20 |
[GO] |
2021―Apr―19 |
Assessment of different laboratory tests for the diagnosis of novel coronavirus infections |
Rozita Ghojoghi, Bahareh Zamani, Abbas Behzad Behbahani |
| 21 |
[GO] |
2021―Feb―21 |
Frequency of underlying diseases, symptoms and mortality rate of COVID-19 |
Morteza Shams, Gholam Basati, Gholamreza Kalvandi, Amir Abdoli, Hamed Tavan |
| 22 |
[GO] |
2021―Jan―20 |
Severe acute respiratory syndrome coronavirus 2 infection in an Iranian HIV-positive patient |
Rahim Raoofi, Mohammad Aref Bagherzadeh, Ahmadreza Bazmjoo, Heshmatollah Shakeri, Alireza Abbasi, Amir Abdoli |
| 23 |
[GO] |
2021―Jan―20 |
The coronavirus disease 2019 and effect on liver function |
Parastoo Hosseini, Shervin Afzali, Mohammadreza Karimi, Milad Zandi, Arghavan Zebardast, Tayebe Latifi, Alireza Tabibzadeh, Akam Ramezani, Armin Zakeri, Amirmohammad Zakeri, Behnam Abedi, Saber Soltani, Abbas Farahani |
| 24 |
[GO] |
2021―Jan―15 |
Genetic and structure of novel coronavirus COVID-19 and molecular mechanisms in the pathogenicity of coronaviruses |
Bahman Yousefi, Majid Eslami |
| 25 |
[GO] |
2021―Jan―15 |
Micronutrient zinc roles in adjunctive therapy for COVID-19 by enhancing patients immunoregulation and tolerance to the pathogen |
Ba Xuan Hoang, Bo Han |
| 26 |
[GO] |
2020―Dec―05 |
Current drugs with potential for coronavirus disease 2019 therapy |
Samin Alihosseini, Hamed Ebrahimzadeh Leylabadlo, Mahdi Parsaei, Nazila Sarafraz, Khudaverdi Ghanbarov, Silvano Esposito, Hossein S. Kafil |
| 27 |
[GO] |
2020―Sep―01 |
Pathophysiology of COVID-19 infection |
Mohammadreza Hashemi Aghdam, Ramin Hosseinzadeh, Behzad Motallebizadeh, Mohammadreza Rezaeimehr, Leila Khedmat, Zahra Soleimani, Mohammad Heiat, Mehrdad Moosazadeh Moghaddam, Mohammadali Abyazi, Ashraf Karbasi |
| 28 |
[GO] |
2020―Sep―01 |
A review on an ongoing pandemic caused by the severe acute respiratory syndrome coronavirus 2 |
Solmaz Ohadian Moghadam |
| 29 |
[GO] |
2020―Sep―01 |
SARS-CoV-2 receptor ACE2 and molecular pathway to enter target cells during infection |
Khadijeh Najafi, Parham Maroufi, Ehsaneh Khodadadi, Elham Zeinalzadeh, Khudaverdi Ganbarov, Mohammad Asgharzadeh, Hossein Samadi Kafil |
| 30 |
[GO] |
2020―Aug―08 |
Cytokine storm is the cryptic killer behind coronavirus disease-2019 infections, review of the current evidence to identify therapeutic options |
Diaa Alrahmany, Islam M. Ghazi |
| 31 |
[GO] |
2020―Jul―16 |
An overview on wearing the face mask to avoid transmission of coronavirus disease 2019 |
Maryam Mohammadbeigi, Maryam Meskini, Safarali Alizadeh Koshkohi |
| 32 |
[GO] |
2020―Jun―23 |
What is the novel coronavirus disease 2019 (COVID-19) that paralyze the world? |
Ali Ozturk, Olkar Abdulmajed, Bashar Ibrahim |
